Clinical Trials
101 trialsVERDI
Dana-Farber Cancer Institute
RABBIT
University of Arizona
The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mayo Clinic
SURVIMON
N.N. Petrov National Medical Research Center of Oncology
LONGEVITI
University of Alberta
Low Dose, Reduced Frequency Nivolumab for the Treatment of Unresectable or Metastatic Cancer, AFFORD IO Trial
Fred Hutchinson Cancer Center
FHAMe
University of Toronto
iCaRe2
University of Nebraska
Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer
Stanford University
CER
Cancer Support Community, Research and Training Institute, Philadelphia
SJFAMILY
St. Jude Children's Research Hospital
PSI-Immune
University of Pittsburgh
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
M.D. Anderson Cancer Center
Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer Patients
M.D. Anderson Cancer Center
PRO-ACTIVE
Fondazione del Piemonte per l'Oncologia
Pembrolizumab (Anti-PD-1) and AMG386 (Angiopoietin-2 (Ang-2) in Patients With Advanced Solid Tumor
Dana-Farber Cancer Institute
PNeoVCA
Mayo Clinic
Navigation Intervention for Adolescent and Young Adult Cancer Survivors
Kaiser Permanente
SELECT-CAR-NK
Essen Biotech
EBNK-ST-001
Essen Biotech
IT-TCP POS
Azienda Ospedaliero-Universitaria di Parma
STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and Melanoma
City of Hope Medical Center
Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors
University of Pittsburgh
Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
University Health Network, Toronto
LIBERATE
University Health Network, Toronto
DETERMINE
Cancer Research UK
DETERMINE
Cancer Research UK
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
West China Hospital
Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy
Memorial Sloan Kettering Cancer Center
AYAConnect
UNC Lineberger Comprehensive Cancer Center
IMPROVE
Memorial Sloan Kettering Cancer Center
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Hadassah Medical Organization
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Hadassah Medical Organization
A Phase I/IIa Trial of HMBD-001 in Advanced HER3 Positive Solid Tumours
Cancer Research UK
DP-PAN-CANCER
Institut Claudius Regaud
NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours
NuCana plc
AM-003
University of Virginia
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
Roswell Park Cancer Institute
MOIO
UNICANCER
Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies
M.D. Anderson Cancer Center
INTROSPECTION
Maria Sklodowska-Curie National Research Institute of Oncology
Improved Early Diagnosis in Female Pelvic Cancer With OC Detect
Region Skane
INSPIRE
University Health Network, Toronto
ACROPOLI
SOLTI Breast Cancer Research Group
MOHCCN-O
University Health Network, Toronto
PragmaTIL
Vall d'Hebron Institute of Oncology
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Stanford University
SPIRIT
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients
Cedars-Sinai Medical Center